REGISTER now: Sweden Event - A new era for innovation: AI, the UPC and global patent opportunities
​

European Pharmaceutical Review: Compulsory licenses in Germany

No items found.
​
11 March 2019
Tags
Litigation
Life
Table of contents
  • Toc Heading
  • Toc Heading

Head of EIP’s Düsseldorf office, Christof Höhne, outlines the implications of Germany’s compulsory licensing in an article for the latest issue of the European Pharmaceutical Review. Two recent, high-profile pharmaceutical cases which have set the course for the future of German IP law are analysed by Christof, who highlights the advantages and disadvantages faced by both parties in a licensing negotiation.

The article can be read on the European Pharmaceutical Review website here.

Related articles

See all articles

EIP named a leading patent firm again in the Legal 500 UK 2027
01 October 2026
EIP has retained its Tier 1 ranking in PATMA: Patents and its Tier 2 ranking in IP: Patents (contentious and non-contentious) in the Legal 500 UK 2027 guide. In addition, Gary Moss was inducted into the Hall of Fame in IP: Patents.
​
Five EIP partners named among the world's leading IP strategists in the 2026 IAM Strategy 300
17 August 2026
Christof Höhne, Darren Smyth, Heather McCann, James Seymour, and Sebastian Fuchs have all been named in this year's list, each recognised for their own approach to building patent value for clients.
​
Stuart Malcolm joins EIP as Partner, Solicitor, strengthening EIP's Commercial practice
17 June 2026
EIP is delighted to announce that Stuart Malcolm has joined EIP as a Partner, Solicitor on 17 June 2026, strengthening our Commercial practice. Stuart brings more than 25 years of experience as a commercial and intellectual property lawyer, with a career spanning private practice, senior in-house leadership, and the United Kingdom's deep tech and innovation sectors.
​